Holds 3 valid CEPs for potassium clavulanate, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
EDQM certificate database
EDQM certificate database
Holds 3 valid CEPs for potassium clavulanate, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 3 valid CEPs for potassium clavulanate, filing since 2025. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 5 markets.
Holds 2 valid CEPs for potassium clavulanate, filing since 2025.
Holds 4 valid CEPs for potassium clavulanate, filing since 2019. Its 2023 FDA inspection closed as OAI, and its GMP is recognised in 3 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Potassium Clavulanate manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free